Pituitary pars intermedia dysfunction (PPID or equine Cushings disease) is a progressive neurological condition affecting an estimated 15-25% of horses over 15 years old, with significant welfare implications if unmanaged.
PPID welfare management is a domain where early diagnosis and systematic treatment produce profoundly different outcomes than missed diagnosis or delayed treatment. Horses with undiagnosed PPID may suffer for extended periods from the consequences of uncontrolled cortisol excess: repeated laminitis episodes causing intense foot pain, progressive muscle wasting reducing mobility and comfort, and immune suppression increasing infection susceptibility. Once diagnosed, pergolide treatment typically produces measurable improvement in clinical signs within weeks — shedding returns, energy improves, and laminitis frequency decreases. The welfare argument for proactive PPID screening in horses over 15 years is strong: ACTH testing is straightforward, and early treatment initiated before severe clinical signs develop produces substantially better long-term welfare outcomes than treatment begun after significant deterioration.